Endo Pharmaceuticals will pay up to $180 million, plus royalties, to BioDelivery Sciences International in a licensing and development agreement to manufacture, distribute, market and sell BEMA Buprenorphine on a global scale, according to a MarketWatch report.
The Latest
A new Millennium Research Group report shows the United States market for orthopedic biomaterials will grow approximately 7 percent over the next four years to reach $4 billion, according to a MRG news release.
A recent examination of the Lachman test for diagnosing anterior cruciate ligament deficiency was recorded in an article published in the American Journal of Sports Medicine.
Wayne, N.J.-based medical device company Cascade Medical Enterprises has sold its technology for platelet-rich plasma and platelet-rich fibrin matrix to Musculoskeletal Transplant Foundation, according to a Cascade Medical news release.
Alphatec Spine has reached a settlement agreement for two pending lawsuits with Cross Medical and a Biomet subsidiary, according to an Alphatec Spine news release.
Alphatec Spine has reached a settlement agreement for two pending lawsuits with Cross Medical and a Biomet subsidiary, according to an Alphatec Spine news release.
Founder and CEO of Business Dynamics Barbara Cataletto has been named to the coding task force for the International Society for the Advancement of Spine Surgery, according to a Long Island Business News report.
Here are 20 spine and neurosurgeons on the move in 2011.
Researchers found spinal manipulation therapy was more effective in reducing neck pain than medication, according to findings published in the Annals of Internal Medicine.
Arcion Therapeutics, a Baltimore-based clinical stage biotechnology company, received notice of allowance for a U.S. patent for its high-strength gel formulation of topical lidocaine, called ARC-2022, for pain associated with post-herpetic neuralgia and shingles, according to a company news release.